首页/数据集/Patients with atrial fibrillation, 85 years or older treated with VKAs or DOACs.

Patients with atrial fibrillation, 85 years or older treated with VKAs or DOACs.

NIAID Data Ecosystem2026-03-11 收录

数据链接：

https://figshare.com/articles/dataset/Patients_with_atrial_fibrillation_85_years_or_older_treated_with_VKAs_or_DOACs_/8176751 数据链接链接失效反馈

官方服务：

资源简介：

Descriptive statistics of baseline features by treatment group.

各治疗组基线特征的描述性统计

应用场景：

创建时间：

2019-05-23

老年房颤抗凝治疗

用药依从性

ObjectiveIn this study, we aimed to assess the utilization pattern (potentially inappropriate dosing and concomitant use of contraindicated drugs) and adherence to direct oral anticoagulants (DOACs),

Figshare2019-04-01 更新20

Supplementary file 1_Impact of levetiracetam on direct oral anticoagulant level and outcomes among older Asian patients with atrial fibrillation.docx

药物相互作用评估

老年房颤抗凝治疗

ObjectiveThis purpose of this study is to analyze the influence of levetiracetam (LEV) on direct oral anticoagulant (DOAC) exposure and its implications for clinical outcomes. MethodsThis investigatio

NIAID Data Ecosystem10

Safety and effectiveness of apixaban in comparison to warfarin in patients with nonvalvular atrial fibrillation: a propensity-matched analysis from Japanese administrative claims data

抗凝药物对比研究

心房颤动卒中防治

Objective: To investigate the risk of bleeding events and stroke/systemic embolism (SE) among Japanese patients with nonvalvular atrial fibrillation (NVAF), focusing on the initial dosage of ap

Taylor & Francis Group2019-03-27 更新00

Events recorded during follow-up in patients 85 years or older with atrial fibrillation, treated with VKAs or DOACs, or DOACs treatment-naive.

老年房颤抗凝治疗

临床结局监测

Events recorded during follow-up in patients 85 years or older with atrial fibrillation, treated with VKAs or DOACs, or DOACs treatment-naive.

NIAID Data Ecosystem20

Events recorded during follow-up in patients 85 years or older with atrial fibrillation, treated with VKAs or DOACs, or DOACs treatment-naive.

老年房颤抗凝治疗

药物随访安全性评估

Events recorded during follow-up in patients 85 years or older with atrial fibrillation, treated with VKAs or DOACs, or DOACs treatment-naive.

Figshare2019-05-23 更新00